Drug Updates

China’s Biopharma Boom Reshapes APAC Market Dynamics

As China’s biopharma sector continues to flourish, the Asia-Pacific (APAC) region is experiencing a substantial transformation in biopharma innovation, outsourcing, and manufacturing. Ian Haydock, Editor-In-Chief, Insights, Asia-Pacific at Citeline, will unpack the far-reaching effects of China’s burgeoning influence during his keynote address at CPHI Japan 2023, scheduled for April 19-21. Recent setbacks in the US […]